UVA Health Newsroom

Latest News

David Schiff in the lobby of UVA's hospital.

December 3, 2024 Trial Identifies Better Treatment for Grade 2 Gliomas

Adding the chemotherapy pill temozolomide to radiation treatment significantly improves survival for adults with brain tumors known as grade 2 gliomas, a clinical trial led by a top UVA Health cancer expert has found.

The exterior of the hospital expansion at UVA Health University Medical Center.

November 27, 2024 UVA Health Salutes Team Members With Donations to 5 Nonprofits

November 25, 2024 UVA Cancer Center Partnering to Expand Lung Cancer Screenings in Rural Virginia, West Virginia

November 21, 2024 Trial Tests Focused Ultrasound to Battle Melanoma

All News

Editor's Picks

See All

UVA Healthy Balance Blog

December 5, 2024 Tomorrow Will Be Better: Follow-Up Surgery for CHD
December 2, 2024 Bladder Cancer Symptoms in Women: Are You Missing the Signs?
November 26, 2024 7 Quick Question With Heart Surgeon Jared Beller

See All

Physician Resource

November 20, 2024 Healing Hearts After a Heart Attack: Unlocking Heart Cell Regeneration
November 18, 2024 Researcher Spotlight: Jamieson Bourque, MD, Unexplained Chest Pain & High-Intensity Exercise
November 18, 2024 Provider Perspectives: A New Care Model Eases Burdens for Parkinson’s Patients & Caregivers

See All

Making of Medicine Blog

November 14, 2024 Surprise Findings About How AI Affects Doctor’s Diagnoses
November 8, 2024 Falling Asleep While Feeding Puts Babies at Risk
October 22, 2024 Imaging Can Let Rectal Cancer Patients Avoid Surgery

See All

Radiology Blog

November 9, 2023 After Lutathera, His Mission is Supporting Others
October 26, 2023 A First Mammogram to Remember
January 20, 2023 Warming Cold Hands: A New Treatment for Raynaud’s Syndrome

See All

Vision and Voice

Wendy Horton, CEO, UVA Medical Center, offers thought leadership and considered reflections on the nature of medicine, healthcare, and policy.

Latest News

Editor's Picks

Trial Tests Focused Ultrasound to Battle Melanoma

Weight-Loss Drug Tirzepatide Reduces Heart Failure Deaths